학술논문

Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial
Document Type
Article
Source
In: JAMA Oncology. (JAMA Oncology, April 2022, 8(4):546-552)
Subject
Language
English
ISSN
23742445
23742437